BioSpace News Archive

Photocure: Partner announces First Patient Procedure with Hexvix in China under Special Access Program

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner and exclusive distributor, Asieris MediTech in mainland China and Taiwan has communicated the first patient experience with Hexvix ® in the Bo’ao Lecheng International Medical Tourism Pilot Zone in Hainan Province.

December 27, 2021
·
6 min read
BioNTech to Present at the 40th Annual J.P. Morgan Healthcare Conference

BioNTech SE will present a corporate overview and update at the virtual 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 9:45 am ET.

December 27, 2021
·
1 min read
Business

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Approved in Japan for Patients With Unresectable, Advanced or Recurrent Endometrial Carcinoma That Progressed After Cancer Chemotherapy

KEYTRUDA ® (pembrolizumab) Plus LENVIMA ® (lenvatinib) Approved in Japan for Patients With Unresectable, Advanced or Recurrent Endometrial Carcinoma That Progressed After Cancer Chemotherapy.

December 27, 2021
·
67 min read
Business

BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES

Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Brenda Everson as Senior Vice President, Human Resources effective January 10, 2022 .

December 27, 2021
·
1 min read
BioMidwest

Soin Therapeutics Completes Formulation Development of Novel Low Dose Naltrexone Tablet to Treat Complex Regional Pain Syndrome

Soin Therapeutics has completed the formulation development work of their novel, proprietary low dose naltrexone pill to treat Complex Regional Pain Syndrome (CRPS).

December 27, 2021
·
2 min read
Drug Development

Sutro Biopharma Announces Company KOL Virtual Event to Provide Interim Dose Expansion Data for Antibody-Drug Conjugate Program STRO-002 for Treatment of Advanced Ovarian Cancer

Dr. Naumann and Sutro management to discuss interim data on the STRO-002 Phase 1 dose-expansion cohort at Company event scheduled for Wednesday, Jan. 5, 2022 at 5 pm ET, or 2 pm PT.

December 27, 2021
·
7 min read
Drug Development

Kintor Pharma Provides Update on One of its Three Multi-Regional Phase 3 Trials of Proxalutamide for COVID-19

Kintor Pharmaceutical Limited today provided an update on its multi-regional study of proxalutamide for the treatment of COVID-19 infection (NCT04870606).

December 27, 2021
·
4 min read
Business

VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine R&D

US-based biotech company VLP Therapeutics, Inc. (VLPT) announced on December 27 that it has signed an agreement for an investment of US$21 million in a Series A-1 round.

December 27, 2021
·
2 min read
FDA

Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML

Celularity Inc. today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its non-genetically modified cryopreserved human placental hematopoietic stem cell-derived natural killer (NK) cell therapy, CYNK-001.

December 27, 2021
·
5 min read
Drug Development

I-Mab Announces IND Approval from China NMPA for Phase 2 Clinical Trial of Enoblituzumab in Combination with Pembrolizumab in Solid Tumors

I-Mab announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has approved I-Mab’s IND submission for the initiation of a phase 2 trial in China for enoblituzumab.

December 27, 2021
·
5 min read